Skip to content

SANUWAVE Health, Inc. SNWV Class Of Warrant Or Right Weighted Average Exercise Price Issued

Class Of Warrant Or Right Weighted Average Exercise Price Issued at other companies

Vista Gold logo
Vista GoldVGZ
$1.25
FIP
FTAI Infrastructure Inc.FIP
$9.76-0.9%
Odysight.ai logo
Odysight.aiODYS
$5.50
NewtekOne, Inc. logo
NewtekOne, Inc.NEWT
$21.03
AMC Robotics Corporation
 logo
AMC Robotics Corporation AMCI
$10.30
Unusual Machines logo
Unusual MachinesUMAC
$0.00-100%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept snwv:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued.

The official record: SANUWAVE Health, Inc.’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s class of warrant or right weighted average exercise price issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s class of warrant or right weighted average exercise price issued?
SANUWAVE Health, Inc. (SNWV) reported class of warrant or right weighted average exercise price issued of $20.06 in Q4 2024.
What does class of warrant or right weighted average exercise price issued mean?
The weighted average price at which new warrants or rights were issued during the reporting period. This metric provides insight into the valuation at which the company is granting potential future equity dilution to investors or stakeholders.